An interventional study of Indirect Calorimetry Group and Control Group - Formula-Based Group in Critical Illness and ICU, sponsored by HEIDEGGER CP. Recruiting at 3 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-19.
Sponsored by HEIDEGGER CP · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This multicentric randomized controlled trial aims to evaluate whether indirect calorimetry (IC)-guided nutritional support improves patient-centered outcomes in critically ill adult patients compared to standard formula-based nutritional strategies. The study includes mechanically ventilated patients expected to remain in the ICU for more than 72 hours. The intervention group will receive nutritional targets based on measured resting energy expenditure using the QNRG+ device, with a gradual escalation of energy delivery following current ESPEN guidelines. The primary outcome is quality of life at 3 months post-ICU admission, assessed using the EQ-5D-5L. Secondary outcomes include functional recovery, muscle preservation, infection rates, and rehospitalization. This study is the first to assess the long-term impact of IC-guided nutrition on recovery and quality of life using a patient-centered approach.
1,787 studies on the registry are indexed under Critical Illness; 445 are open to participants now.
This study's planned enrollment of 356 is above the median of 90 across 930 interventional studies indexed under Critical Illness.
Browse Critical Illness studies →HEIDEGGER CP is the lead sponsor of 3 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
All patients admitted to the ICU with the following criteria:
Exclusion Criteria:
Other: Indirect Calorimetry Group
Other: Control Group - Formula-Based Group
* Nutritional targets measured by IC starting on Day 4 * Repeated IC measurements 2 times weekly performed with the QNRG+ device * Gradual escalation to 80%-100% caloric coverage by Day 4
* Nutritional targets determined using predictive equations (pragmatic, set at local level) * Escalation as per local protocol
Quality of life (EQ-5D-5L)
Measured using the EQ-5D-5L: 0-100
Time frame: At 3 months after ICU admission
Mortality
Time frame: Up to 3 months after ICU admission
Nosocomial infection
Defined as the initiation of a new antibiotic treatment lasting at least 72 hours, associated with a documented diagnosis of infection in the patient's chart
Time frame: Up to 28 days after ICU admission
Pressure soar
Time frame: Up to 28 days after ICU admission
Energy deficit in kcal
according to the energy target defined by IC or predictive formula depending on the randomization group
Time frame: Up to 28 days after ICU admission
Protein deficit in grams
according to the protein target defined by predictive formula
Time frame: Up to 28 days after ICU admission
Ventilation-free days
Time frame: Measured at day 28 after ICU admission
ICU free-days
Time frame: Measured at day 28 after ICU admission
Functional recovery: Bartel Index
Using Barthel Index: 0-100
Time frame: At ICU discharge or up to 28 days after ICU admission and at 3 months after ICU discharge
Gerneral well-being: Edmonton Symptom Assessment Scale
Using Edmonton Symptom Assessment Scale (ESAS) : 0-90
Time frame: At ICU discharge or up to 28 days after ICU admission and at 3 months after ICU discharge
Readmission and rehospitalization rates
Time frame: Until 3-month post-ICU admission
Discharge place
Time frame: Until 3 months after ICU admission
Return to work
Time frame: Until 3 months after ICU admission
Disability and functioning: WHO Disability Assessment Schedule
Using WHO Disability Assessment Schedule (WHODAS 2.0): 0-48
Time frame: At 3-month post ICU admission
Disability and functioning: Clinical Frailty Scale
Using Clinical Frailty Scale (CFS): 1-9
Time frame: At 3-month post ICU admission
Disability and functioning: Short-form 12
Using Short-form 12 (SF-12): 0-100
Time frame: At 3-month post ICU admission
Disability and functioning: MOCA-5
Using montreal cognitive assessment- 5 min (MOCA-5): 0-15
Time frame: At 3-month post ICU admission
Disability and functioning: Patient Health Questionnaire-9
Using Patient Health Questionnaire-9 (PHQ-9): 0-27
Time frame: At 3-month post ICU admission
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Jun 2027, 17 months after the start.
Of 405 non-industry interventional studies with no phase under Critical Illness, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 40. This study's planned 17 months is below that.
Counting every sponsor, half of 409 studies reached it within 21 months; a quarter within 11 and three quarters within 40.
Critical Illness covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
HEIDEGGER CP